GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Cu²⁺; MW 340 Da) is a naturally occurring copper-chelating tripeptide that functions as one of the most pleiotropic bioregulatory peptides known to science. It modulates the expression of >130 human genes across tissue repair, oncology, neurodegeneration, and anti-inflammatory pathways, making it an indispensable research tool for regenerative medicine, cancer biology, neuroprotection, gene expression profiling, and wound healing science.
Advanced Research Applications
Key Technical Specifications
|
Peptide Name |
GHK-Cu (Copper Tripeptide-1) |
|
INCI / Common Name |
Copper Tripeptide-1 |
|
Structure |
GHK-Cu²⁺ (square-planar copper chelate; 3N coordination) |
|
Molecular Weight |
340 Da |
|
Purity |
≥98% by RP-HPLC |
|
Primary Targets |
Cu-dependent enzymes (SOD1, LOX); NF-κB; VEGF/HIF-1α; 130+ |
|
Key Research Areas |
Oncology, Neuroprotection, Wound Healing, Angiogenesis, |
|
Form |
Lyophilized Powder |
|
Solubility |
Freely soluble in water (≥10 mg/mL); stable in PBS at pH 7.0–7.4 |
|
Storage |
−20°C, desiccated, dark; avoid UV; stable ≥24 months when |
|
CAT Number |
PS-SYN-SIG-003 |
|
Pack Sizes |
10 g | 50 g | 100 g |
|
Regulatory Status |
For Research Use Only |